Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGF vs GFF in Moderate-to-severe COPD
NCT04675463Unknown
- Start
- Dec 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of budesonide in chronic obstructive pulmonary disease (COPD) (2 arms). Primary endpoint: The effect of BGF and GFF on inner luminal area change at 12 months. Status: unknown.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04675463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04675463.